US 11318186
Use of FGF21 in methods of increasing exocrine pancreatic secretion
granted A61KA61K38/1825A61K9/0019
Quick answer
US patent 11318186 (Use of FGF21 in methods of increasing exocrine pancreatic secretion) held by The Board of Regents of the University of Texas System expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/1825, A61K9/0019, A61K9/0053, A61P